All posts by: Michael Zand

About Michael Zand

Gene therapy for rare form of blindness wins US approval – ABC News

Continue reading

2017-12-19 NEWS

Gene therapy for rare form of blindness wins US approval
ABC News
U.S. health officials on Tuesday approved the nation’s first gene therapy for an inherited disease, a treatment that improves the sight of patients with a rare form of blindness. It marks another major advance for the emerging field of genetic medicine

and more »

Continue reading

2017-12-19 NEWS

Gene therapy for rare form of blindness wins US approval
Seattle Times
WASHINGTON (AP) — U.S. health officials have approved a breakthrough therapy that can improve the eyesight of patients with a rare form of inherited blindness. Tuesday’s approval of the treatment from Spark Therapeutics is another major advance for

Continue reading

2017-12-19 NEWS

Business Insider

The FDA just approved the first gene therapy to treat blindness
Business Insider
The US Food and Drug Administration just approved a cutting-edge gene therapy. The treatment, called Luxturna and made by Spark Therapeutics, treats Leber congenital amaurosis, a hereditary form of blindness. It’s been tested in people with the

and more »

Continue reading

2017-12-19 NEWS

Forbes

FDA approves novel gene therapy to treat patients with a rare form of inherited vision loss
FDA.gov
“Today’s approval marks another first in the field of gene therapy — both in how the therapy works and in expanding the use of gene therapy beyond the treatment of cancer to the treatment of vision loss — and this milestone reinforces the potential
Gene therapy for rare form of blindness wins US approvalABC News
After Decades, A Gene Therapy Is Approved. Next: The Debate On PriceForbes
The FDA just approved the first gene therapy to treat blindnessBusiness Insider
CNBC –Scientific American
all 17 news articles »
Continue reading

2017-12-19 NEWS

FDA approves novel gene therapy to treat patients with a rare form of inherited vision loss
FDA.gov
“Today’s approval marks another first in the field of gene therapy — both in how the therapy works and in expanding the use of gene therapy beyond the treatment of cancer to the treatment of vision loss — and this milestone reinforces the potential